West Family Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,269,799
Closed -$3.61M 128
2020
Q3
$3.61M Buy
1,269,799
+730,349
+135% +$2.33M 1.36% 21
2020
Q2
$1.75M Sell
539,450
-85,333
-14% -$270K 0.42% 45
2020
Q1
$1.76M Buy
624,783
+85,333
+16% +$275K 0.7% 40
2019
Q4
$1.75M Hold
539,450
0.42% 45
2019
Q3
$1.17M Hold
539,450
0.29% 54
2019
Q2
$1.69M Sell
539,450
-61,300
-10% -$199K 0.43% 49
2019
Q1
$2.23M Sell
600,750
-80,200
-12% -$271K 0.56% 43
2018
Q4
$1.98M Buy
680,950
+53,150
+8% +$146K 0.51% 46
2018
Q3
$1.65M Buy
627,800
+289,659
+86% +$711K 0.39% 53
2018
Q2
$791K Buy
+338,141
New +$944K 0.2% 64

Other funds holding PDLI

West Family Investments's PDLI Position: Q4 2020 in Review

West Family Investments sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 1,269,799 shares — an estimated $3.61M sold.

West Family Investments first reported a position in PDLI in Q2 2018 and held it in 10 quarters. The position peaked at $3.61M in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • West Family Investments reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • West Family Investments sold 1,269,799 PDL BioPharma, Inc. shares in Q4 2020, an estimated $3.61M.
  • West Family Investments first reported a position in PDL BioPharma, Inc. in Q2 2018 and held it in 10 quarters.
  • West Family Investments's PDL BioPharma, Inc. position peaked at $3.61M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on West Family Investments's 13F filing for Q4 2020, filed 16 Feb 2021.